NARB Newsletter Sections

Showing posts with label NARB in the News. Show all posts
Showing posts with label NARB in the News. Show all posts

Monday, February 8, 2010

NARB panel confirms recommendations to PatentHEALTH

Source: Tan Sheet


The National Advertising Review Board agrees with earlier recommendations by the National Advertising Division that PatentHEALTH discontinue claims that Trigosamine Fast Acting joint health supplement "works" or "gets results" in three days. The claims in question were not supported by a randomized, double-blind, placebo-controlled study submitted by the Canton, Ohio-based firm, the Council of Better Business Bureaus panel reaffirms in a review of an appeal by PatentHEALTH. Additionally, the board sided with NAD that an advertorial for the product reasonably could be perceived by consumers to be a news story. Therefore, the panel recommended the firm discontinue any ads "not clearly and conspicuously identified as an advertisement." PatentHEALTH, which appealed NAD's decision last summer, says it will give "due consideration" to the panel's recommendations.

Tuesday, December 1, 2009

NARB denies Novartis' appeal for Excedrin ad claims

Source - Drug Store News - 11/30/09
By Michael Johnsen

NEW YORK (Nov. 30) The National Advertising Review Board last week denied an appeal made by Novartis Consumer Health around the advertising claim that Extra Strength Excedrin relieves pain after 15 minutes.

Following a challenge made by Wyeth Consumer Healthcare, the National Advertising Division of the Council of Better Business Bureaus had advised Novartis to discontinue the 15-minute claim.
The challenged television advertisement showed a woman suffering from a headache sitting at a table at an outdoor cafe. A digital clock rapidly advances below her. When the clock indicates 10 minutes had passed, a voiceover asks: “What’s the only gel tab with a triple-ingredient formula to start relieving your headache in just 15 minutes?”

At the 15-minute mark, the woman’s facial expression dramatically changes and she gets up, smiling, to greet someone. The voiceover answers the question by stating “Extra Strength Excedrin. Go.”

Novartis provided a proprietary clinical study that tested Extra Strength Excedrin to determine its efficacy in relieving pain intensity for episodic tension-type headaches, and argued that the clinical trial was sufficient to support an “onset of action” claim that Extra Strength Excedrin started to work on a pharmacological basis after 15 minutes.

The appeal panel agreed with NAD’s initial finding that the proffered substantiation did not provide support for the reasonably conveyed message that typical consumers can reasonably expect a reduction in headache pain within 15 minutes of taking Extra Strength Excedrin.
Novartis agreed to follow NARB's recommendation.

Excedrin Doesn't Relieve Headaches in 15 Minutes, Despite What Ads Said

Source: BNET – 11.25.09

Novartis (NVS) should discontinue ads that say its Extra Strength Excedrin starts to relieve headaches in 15 minutes, according to the National Advertising Review Board, an appeals body that governs disputes between advertisers.

Download the ruling here.
Wyeth (now Pfizer - PFE), maker of Advil, had originally complained that Excedrin does not relieve headaches in 15 minutes. That dispute, heard by the The National Advertising Division of the Council of Better Business Bureaus, had also determined that Novartis’ Excedrin claim was bogus. Adweek:

Looking at Novartis’ study, the NAD found that the “statistically significant” number of respondents who reported feeling better 15 minutes after taking Extra-Strength Excedrin was “very small.”

Novartis appealed to NARB and the decision was upheld: Excedrin doesn’t really start to alleviate your headache in 15 minutes. This time Novartis has agreed to end its commercials. Indeed, they’ve disappeared from this page where they used to be.

And finally: Wasn’t the Excedrin account last seen at Saatchi & Saatchi?

Wednesday, November 25, 2009

Group recommends Wrigley not overstate gum's benefits

Source: Chicago Tribune – 11.24.09

An advertising self-regulatory group announced Thursday it has upheld a decision challenging advertising claims made by Chicago-based Wm. Wrigley Jr. Co. for its Eclipse gum.

In 2008, Wrigley launched a new version of Eclipse touting the gum's ability to kill germs that cause bad breath, courtesy of a new ingredient called magnolia bark extract. But Wrigley's main U.S. gum rival, Cadbury Adams USA, complained about Wrigley's assertions to the Council of Better Business Bureaus' National Advertising Division.

In April, the ad review body ruled that claims of Eclipse's germ-killing prowess were not fully backed by scientific evidence. Wrigley in turn said it was confident of scientific support for its claim, and lodged an appeal to the Better Business Bureau's National Advertising Review Board.

Thursday, the review board essentially concurred with the decision of the National Advertising Division, recommending that Wrigley "avoid stating or implying that it has been scientifically proven" that magnolia bark extract in Eclipse kills or helps kill germs that cause bad breath.

The review board agreed, though, with the original decision last spring that Wrigley can advertise that there's "emerging evidence" of magnolia bark extract's ability to kill germs that cause bad breath.

"Wrigley agreed to take the panel's recommendations into consideration in future advertising," the ad review board said.

Wrigley couldn't be immediately reached for comment.

The Better Business Bureau's advertising regulatory group has no enforcement powers, but it can alert federal trade regulators to spurious claims. Once an appeal is denied, advertisers don't often continue making claims.

Wrigley Advised to Freshen Eclipse Ad Claims

Source: Brandweek – 11.24.09

Assertions made on behalf of the gum brand draw fire from NARB

The National Advertising Review Board has recommended that Wrigley make radical changes to advertising for its Eclipse Gum. After reviewing the company's research and marketing messages, the New York-based group has advised that the gum maker discontinue the claim that "most other gums just mask bad breath."

NARB also suggested that Eclipse ads should avoid stating or implying that it has been scientifically proven that the magnolia bark extract in the gum kills or helps kill germs that cause bad breath. Additionally, NARB said Wrigley shouldn't state that Eclipse's new formulation works better than the original. (NARB is the appeals division of the National Advertising Review Council, the ad industry's self-regulatory system.)

Cadbury Adams USA challenged its competitors' claims with the National Advertising Division. It took exception to ad copy that said, among other things: "Now Eclipse contains a natural ingredient, scientifically proven to help kill the germs that cause bad breath" and "Most other gums just mask bad breath. We kill the germs that cause it." Energy BBDO is Eclipse's lead agency.

The NAD sided with Cadbury. Wrigley appealed the NAD's decision with NARB, which has now rejected that appeal.

At best, the organization said, Wrigley can advertise that there is emerging evidence of magnolia bark extract's ability to kill germs that cause bad breath.

"Wrigley respectfully disagrees with the NARB's findings and stands behind the scientific research regarding Eclipse gum with magnolia bark extract," said Wrigley representative Jennifer Jackson Luth. "We do appreciate the time and support shown by the NARB during this self-regulatory process and will consider the panel's recommendations for future advertising."

Wrigley spent $50 million advertising the Eclipse brand last year (excluding online), per Nielsen. For the first nine months of this year, it spent $17 million.

Wednesday, June 24, 2009

Castrol Loses Appeal on Sludge Claims

Source: Lube Report Blog
By George Gill

BP Lubricants agreed to withdraw its challenged advertising for Castrol GTX motor oil after a National Advertising Review Board panel recommended it discontinue a variety of sludge protection superiority claims in all media.

BP America had appealed the findings last October of the National Advertising Division of the Council of Better Business Bureaus, which – following a challenge by Pennzoil-Quaker state of sludge protection claims in Castrol GTX advertising – had recommended BP America modify or discontinue the disputed advertising claims.

“We at Pennzoil are extremely pleased that the NARB not only upheld the original NAD decision that Castrol discontinue its ’57 percent better’ claim in television advertising, but also went further and determined that this superiority claim and the claim that Castrol GTX passed the ‘industry's toughest sludge standard’ should be discontinued in all media,” Luis Guimaraes, general manager for Shell Lubricants’ North America marketing, told Lube Report. “We trust that Castrol will act promptly in discontinuing the challenged advertising claims.”

The NARB announced the panel’s decision yesterday. “While we respectfully disagree with the panel’s conclusions, as a strong supporter of the self-regulatory process, BP Lubricants will withdraw the challenged advertising,” BP said in its statement responding to the panel’s decision. The record before the NAD and the panel established that engine sludge should be an important concern for consumers, BP stated, and that car makers and many others in the industry believe minimum standards for sludge protection don’t go far enough. “We are disappointed that the panel felt that the substantiation we placed in the record in this matter was insufficient, and that we did not adequately anticipate the need to provide extensive substantiation concerning the characteristics and relevance of the Mercedes Benz M111 [sludge] test, which is part of the European ACEA industry standard,” the company stated. “We had believed that issue was not in contention.”

According to the panel’s decision report, the record does not establish that the M111 is the “industry’s toughest sludge standard.” The panel said that in addition to relying on a European industry standard in advertising directed to North American consumers, BP America did not submit evidence to establish the M111 test was “tougher” than all other industry sludge standards.

The panel also noted that BP America relied on the results of two tests conducted under M271, a proprietary Mercedes-Benz protocol, on different dates – once on Castrol GTX, and once on a competitive Pennzoil product.

“The information submitted by BP America did not demonstrate that the M271 test on which it relies is an appropriate basis for comparative sludge protection claims,” the appeals panel stated. “The test procedures and protocols are not publicly available, and thus NAD was not able to evaluate the test. In addition, there is no published reference data with respect to the M271 test, no correlation to other tests, no field correlation, no published repeatability or reproducibility statistics, and no way to evaluate the statistical significance of the test results.”

Friday, June 5, 2009

An Appeal to the Ad Regulator's Reason

Source: Campaign (UK) -- 06.05.09

So, your ad's been banned. What do you do next? Anything? The current review of the Codes of Advertising Practice should offer advertisers a new appeals process, Brinsley Dresden argues. The American Revolution was triggered by a simple principle: no taxation without representation. When the Advertising Standards Authority took over responsibility for broadcast advertising regulation in 2004, advertisers also took over the responsibility for funding it, by way of its own taxation system: the 0.1 per cent broadcast advertising standards board of finance levy. Unlike a normal tax, the levy is voluntary. And in the vast majority of cases, advertisers accept that the ASA reaches the right conclusions about complaints against ads. But if the current review of the Advertising Codes of Practice is to avoid its own Revolution, we need a new system of representation for advertisers whose ads have been banned.

COUNTING THE COST OF AN AD BAN Every year there are a handful of hard cases where advertisers feel that the paper-based process has failed them - such as Oasis, Swiftcover and Courage - with severe consequences, including wasted production and media costs. They may also incur substantial losses if they cannot advertise for another year, because their annual advertising budget has been exhausted, with a commercial that they intended to run for a year only running for a few weeks, or even a few days. The current economic climate simply serves to underline the imperative of certainty. For the ad agencies concerned, there can also be a fatal strain on the client relationship if a campaign is banned in short order. In order to maintain the support of advertisers and provide the fairness and transparency that should be integral to a self-regulatory system, there should be a new appeal system. For a precedent, look no further than the US and the National Advertising Review Board, which takes appeals from decisions made by the National Advertising Division.

WHY THE SYSTEM NEEDS FIXING Change is needed because television commercials have already been through the rigours of the Clearcast prior approval process, both at script stage and as completed films. Advertisers, then, have a legitimate expectation that their commercials will be able to withstand any regulatory challenge. The problem is compounded by the very restrictive terms of reference used by the current system of independent review. Under the system, an advertiser must show the independent reviewer that there has either been a substantial procedural flaw or that there is new evidence. According to the ASA annual report, no advertiser managed to satisfy those criteria for a banned TV ad last year. In theory, an advertiser could then apply to court for judicial review In practice, however, this is rarely a practical option. Not only is it slow and expensive, but the bar is set very high, with an advertiser having to show that the adjudication was one that no reasonable body could have made. In reality, the issues are usually far more subtly nuanced. The advertiser may simply believe the ASA reached the wrong conclusion, not that it was completely unreasonable. The problems are compounded by the fact that the risks faced by advertisers have grown considerably in recent years. The one-stop shop makes it easier for consumers, competitors and non-governmental organisations to complain, and that is no bad thing. The ASA has also done a good job of raising its profile and educating the public. And various legal developments often leave the ASA as the only recourse against comparative ads. Other problems may stem from the ASA's lack of a clear standard of proof for substantiation; the confusion between the requirement that an advertisement is not misleading and a requirement that it is accurate on any interpretation; and conflicting policies adopted by different regulators. Some recent decisions bear this out. In September 2008, an ad for ExxonMobil was banned because of a claim that liquefied natural gas is a comparatively clean fuel, but did not expressly state that this is by comparison with other fossil fuels, rather than renewable energy sources. On a careful contextual analysis of the individual wording of the script, the complaint could be justified. But on the broader question of whether anybody would be misled or confused, the case against the commercial was rather weak. Even more contentious was the decision in October 2008 to ban the commercial for the Coca-Cola fruit juice drink Oasis, featuring the 'Cactus Kid' character, because it allegedly condoned teenage sex. The commercial had been carefully scrutinised and approved by Clearcast, as usual. However, shortly after its first airing, the commercial was pulled by the ASA and then banned, having attracted a total of 32 complaints from members of the public. This was simply one regulator coming to a different view from another about very subjective questions of taste and decency. But if there is to be a new appeal system to meet the needs and expectations of advertisers, it must not be open to abuse, and it must not impose a disproportionate burden to the ASA's already over-stretched resources.

TIME FOR A NEW APPEAL SYSTEM Initially, an independent 'gatekeeper' would need to decide if there was a substantial likelihood of a different decision on appeal, to filter out frivolous or vexatious appeals. There would need to be a time limit for lodging an appeal and the commercial would also need to be withdrawn pending the appeal. The advertiser would need to specify the reasons for the appeal and pay an application fee to defray some or all of the ASA's costs. Applications would have to come from the advertiser's chief executive or equivalent. Further negative publicity and additional costs should also deter frivolous applications. A panel of adjudicators, separate from the ASA council, could be selected from among a wider standing group of individuals from advertisers, agencies and members of the public. Although the panel members would need to be independent of the ASA, it could include retired ASA council members and draw on their experience. Written briefs could be submitted and circulated in advance by the ASA, the advertiser, the complainant and Clearcast, setting out their respective responses to the appeal. The appeal itself would comprise a round table meeting to review the issues. By allowing oral discussion between the parties and their experts, it should be possible to come to a more informed conclusion that commands the confidence of all the parties. Following the all-parties meeting, the decision would be reached by the panel and its own advisors, if any. A draft decision with a rationale would be circulated for comment in advance of its final adoption. Although the ASA may be concerned about the time and expense of an appeal system, it would act as a pressure valve, strengthening the system overall and helping to ensure the continuing support of advertisers who bankroll self-regulation through the BASBOF levy. The code review consultation, which ends on 19 June, is a once-in-a-generation opportunity to lobby for changes to the self-regulatory system, and the ad industry should not spurn it. After all, we don't need an American Revolution, just a very British tweak.

Brinsley Dresden is a partner specialising in media brands and technology at Lewis Silkin.

Tuesday, March 10, 2009

P&G Lawyer Calls Upon Ad Industry to Work at Defending Self-RegulationAt ANA Conference

NEW YORK (AdAge.com) -- A top lawyer for Procter & Gamble called upon industry executives to work harder than ever to defend self-regulation of the ad business at a gathering of top advertisers today.

Speaking about the tough economic environment and increased government involvement in business affairs, Deborah Platt Majoras, VP-general counsel at P&G, said the ad business has to tout that it has been responsible and doesn't need additional oversight.
The current business environment -- one in which market failures have prompted government bailouts and heightened government oversight -- is leading to a more skeptical outlook from policymakers about self-regulation. '

"The road ahead is not going to be easy, but we are not helpless," said Ms. Majoras, who, prior to joining P&G served as chairman of the Federal Trade Commission from 2004 to 2008. "The industry has been far more responsible than we get credit for. It's time that we backed up rhetoric with facts," she said.

An optimistic start
Ms. Majoras, the keynote speaker at the Association of National Advertisers' Advertising Law and Business Affairs Conference, kicked off the conference on an optimistic note this morning. As is the case with most events these days, attendance for the two-day affair in New York is down. Nearly 150 executives registered for the conference this year, a 25% drop-off from the 200 or so who registered in 2008, organizers said.

Ms. Majoras expressed confidence that the FTC, under new leadership in Jon Leibowitz, is willing to give self-regulation a chance. At the same time, the ball is in the industry's court, she said. Advertisers shouldn't wait for mandates to be handed down from regulators, but rather take it upon themselves to be more responsible.

Among other things, everyone must step up efforts to advertise at a high level of effectiveness, only make claims that can be substantiated, and ensure protection of consumers' privacy. Advertisers should be thinking about making disclosures about their marketing practices, regardless of whether or not the FTC requires them.

"We can't foster trust with consumers now if they feel like they've been had," Ms. Majoras said. The online space is one in which advertisers must be particularly cautious -- and transparent -- because consumers feel a unique sense of ownership over the internet.

Making the case
Ms. Majoras, referencing Rance Crain's recent column in Ad Age, "Self-Regulation Shouldn't Be Advertising's Best-Kept Secret," stressed that steadfast believers in self-regulation must be prepared to "make the case," and should think about ways to better articulate and get the message out there.

She also reiterated a few talking points for the audience, including that the ad industry's system of regulation is flexible, prompt and responsive; it benefits from the accumulated judgment of industry experts; there is an inherent buy-in for the system, which makes it effective; and the cost burden falls upon industry participants rather than taxpayers.